Pharma Journalist -

Artemis Therapeutics announced the appointment of Brian M. Culley, M.A., M.B.A. as its Chief Executive Officer. Mr. Culley is an entrepreneurial and innovative biotech executive with 25…
Read More...

Incyte Corporation and MacroGenics, Inc. announced that the companies have entered into an exclusive global collaboration and license agreement for MacroGenics’ MGA012, an…
Read More...

Ortek Therapeutics announced that the Ortek ECD™ received 510(k) clearance from the U.S. Food and Drug Administration. The ECD is a patented lightweight tabletop device designed as an…
Read More...

TiGenix NV announces that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to Cx601 for the treatment of patients with fistulizing Crohns disease.…
Read More...

Imprimis Pharmaceuticals announced that it is making compounded Cyclosporine-based formulations available for physicians to consider prescribing as customizable and potentially…
Read More...

Catalent announced that it has completed the acquisition of Cook Pharmica LLC, an integrated provider of drug substance and drug product manufacturing and related services. The…
Read More...

Recipharm has equipped its sixth facility with serialisation capabilities ahead of the US and European regulation enforcement deadlines. The facility in Lisbon is the latest of…
Read More...

Vetter announced a major expansion of its secondary packaging capacities as a response to rising customer needs and market demands for complex packaging solutions. The need for…
Read More...

Quotient Clinical announced that it has signed an agreement with Nuformix Technologies Limited (a wholly owned subsidiary of Nuformix plc, ‘Nuformix’), to evaluate the clinical…
Read More...

Alcami Corporation announces the launch of its international sales office in Tokyo, Japan. The company is expanding its presence in Japan to remain at the forefront of market demands…
Read More...